CytoSorbents Corporation (CTSO)

[cars100cars]

Orangecat, good recalling how DC made us all aware months ago of the importance of reducing free hemoglobin in prolonged cardiac surgeries for certain patients. It sounds impressive and important. But I wonder why it takes so long for the FDA to light a fire under the next study phase. The data exist to prove the CytoSorb is an excellent product for further study. We know the aging population is having these types of surgeries with more frequency every year. Yet the FDA and CTSO seem to have no urgency to getting the next study phase done. It's baffling to me, as if a bunch of docs in patent leather shoes are sitting around a conference table simply waiting for the next pot of coffee to be served while they chat idly about it. Pears would agree that the lack of urgency, the lack of pushing by CTSO and the lack of pulling by the FDA to get this product approved begs the question of who is running the show. Someone needs to bust through this logjam and light a fire under the Cardiac Surgery Indication. People in the US are recovering slower, enduring more serious complicating events and perhaps even dying without CytoSorb to aid their recoveries after cardiac surgery. All we can do is sit as investors, watch the clock tick by tick, and wait for Phase II/III to get into gear. Yawn...Tick.....Tock...Tick...Tock